Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Neurodegenerative Diseases Drug Market Status and Forecast (2016-2027)
1.3.2 Global Neurodegenerative Diseases Drug Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Neurodegenerative Diseases Drug Supply by Company
2.1 Global Neurodegenerative Diseases Drug Sales Value by Company
2.2 Neurodegenerative Diseases Drug Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Neurodegenerative Diseases Drug Market Status by Type
3.1 Neurodegenerative Diseases Drug Type Introduction
3.1.1 Immunomodulator
3.1.2 Interferons
3.1.3 Decarboxylase Inhibitors
3.1.4 Dopamine Agonists
3.1.5 Others
3.2 Global Neurodegenerative Diseases Drug Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Neurodegenerative Diseases Drug Market Status by Application
4.1 Neurodegenerative Diseases Drug Segment by Application
4.1.1 Multiple Sclerosis
4.1.2 Parkinson’s Disease
4.1.3 Alzheimer’s Disease
4.1.4 Spinal Muscular Atrophy (SMA)
4.1.5 Others
4.2 Global Neurodegenerative Diseases Drug Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Neurodegenerative Diseases Drug Market Status by Region
5.1 Global Neurodegenerative Diseases Drug Market by Region
5.2 North America Neurodegenerative Diseases Drug Market Status
5.3 Europe Neurodegenerative Diseases Drug Market Status
5.4 Asia Pacific Neurodegenerative Diseases Drug Market Status
5.5 Central & South America Neurodegenerative Diseases Drug Market Status
5.6 Middle East & Africa Neurodegenerative Diseases Drug Market Status
6 North America Neurodegenerative Diseases Drug Market Status
6.1 North America Neurodegenerative Diseases Drug Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Neurodegenerative Diseases Drug Market Status
7.1 Europe Neurodegenerative Diseases Drug Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Neurodegenerative Diseases Drug Market Status
8.1 Asia Pacific Neurodegenerative Diseases Drug Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Neurodegenerative Diseases Drug Market Status
9.1 Central & South America Neurodegenerative Diseases Drug Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Neurodegenerative Diseases Drug Market Status
10.1 Middle East & Africa Neurodegenerative Diseases Drug Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Neurodegenerative Diseases Drug Market Forecast by Type and by Application
12.1 Global Neurodegenerative Diseases Drug Sales Value Forecast (2022-2027)
12.2 Global Neurodegenerative Diseases Drug Forecast by Type
12.3 Global Neurodegenerative Diseases Drug Forecast by Application
13 Global Neurodegenerative Diseases Drug Market Forecast by Region/Country
13.1 Global Neurodegenerative Diseases Drug Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 UCB S.A
14.1.1 Company Information
14.1.2 Neurodegenerative Diseases Drug Product Introduction
14.1.3 UCB S.A Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Teva Pharmaceuticals
14.2.1 Company Information
14.2.2 Neurodegenerative Diseases Drug Product Introduction
14.2.3 Teva Pharmaceuticals Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Sanofi
14.3.1 Company Information
14.3.2 Neurodegenerative Diseases Drug Product Introduction
14.3.3 Sanofi Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Roche
14.4.1 Company Information
14.4.2 Neurodegenerative Diseases Drug Product Introduction
14.4.3 Roche Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Pfizer
14.5.1 Company Information
14.5.2 Neurodegenerative Diseases Drug Product Introduction
14.5.3 Pfizer Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Orion Pharma Ltd
14.6.1 Company Information
14.6.2 Neurodegenerative Diseases Drug Product Introduction
14.6.3 Orion Pharma Ltd Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Novartis
14.7.1 Company Information
14.7.2 Neurodegenerative Diseases Drug Product Introduction
14.7.3 Novartis Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Mitsubishi Tanabe Pharma America
14.8.1 Company Information
14.8.2 Neurodegenerative Diseases Drug Product Introduction
14.8.3 Mitsubishi Tanabe Pharma America Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Lundbeck Pharmaceuticals Italy S.p.A.
14.9.1 Company Information
14.9.2 Neurodegenerative Diseases Drug Product Introduction
14.9.3 Lundbeck Pharmaceuticals Italy S.p.A. Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Biogen
14.10.1 Company Information
14.10.2 Neurodegenerative Diseases Drug Product Introduction
14.10.3 Biogen Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 ACADIA Pharmaceuticals Inc.
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Neurodegenerative Diseases Drug Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Neurodegenerative Diseases Drug Sales Value (Million USD) by Company (2019-2021)
Table Global Neurodegenerative Diseases Drug Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Neurodegenerative Diseases Drug Sales Area
Table Neurodegenerative Diseases Drug Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Neurodegenerative Diseases Drug Sales Value (Million USD) by Type (2016-2021)
Table Global Neurodegenerative Diseases Drug Sals Value Market Share by Type (2016-2021)
Table North America Neurodegenerative Diseases Drug Sales Value (Million USD) by Type (2016-2021)
Table North America Neurodegenerative Diseases Drug Sales Value Market Share by Type (2016-2021)
Table Europe Neurodegenerative Diseases Drug Sales Value (Million USD) by Type (2016-2021)
Table Europe Neurodegenerative Diseases Drug Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Neurodegenerative Diseases Drug Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Neurodegenerative Diseases Drug Sales Value Market Share by Type (2016-2021)
Table Central & South America Neurodegenerative Diseases Drug Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Neurodegenerative Diseases Drug Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Neurodegenerative Diseases Drug Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Neurodegenerative Diseases Drug Sales Value Market Share by Type (2016-2021)
Table Global Neurodegenerative Diseases Drug Sales Value (Million USD) by Application (2016-2021)
Table Global Neurodegenerative Diseases Drug Value Market Share by Application (2016-2021)
Table North America Neurodegenerative Diseases Drug Sales Value (Million USD) by Application (2016-2021)
Table North America Neurodegenerative Diseases Drug Sales Value Market Share by Application (2016-2021)
Table Europe Neurodegenerative Diseases Drug Sales Value (Million USD) by Application (2016-2021)
Table Europe Neurodegenerative Diseases Drug Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Neurodegenerative Diseases Drug Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Neurodegenerative Diseases Drug Sales Value Market Share by Application (2016-2021)
Table Central & South America Neurodegenerative Diseases Drug Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Neurodegenerative Diseases Drug Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Neurodegenerative Diseases Drug Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Neurodegenerative Diseases Drug Sales Value Market Share by Application (2016-2021)
Table Global Neurodegenerative Diseases Drug Sales Value (Million USD) by Region (2016-2021)
Table Global Neurodegenerative Diseases Drug Value Market Share by Region (2016-2021)
Table North America Neurodegenerative Diseases Drug Sales Value (Million USD) by Country (2016-2021)
Table North America Neurodegenerative Diseases Drug Value Market Share by Country (2016-2021)
Table Europe Neurodegenerative Diseases Drug Sales Value (Million USD) by Country (2016-2021)
Table Europe Neurodegenerative Diseases Drug Value Market Share by Country (2016-2021)
Table Asia Pacific Neurodegenerative Diseases Drug Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Neurodegenerative Diseases Drug Value Market Share by Country (2016-2021)
Table Central & South America Neurodegenerative Diseases Drug Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Neurodegenerative Diseases Drug Value Market Share by Country (2016-2021)
Table Middle East & Africa Neurodegenerative Diseases Drug Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Neurodegenerative Diseases Drug Value Market Share by Country (2016-2021)
Table Global Neurodegenerative Diseases Drug Value (Million USD) Forecast by Type (2022-2027)
Table Global Neurodegenerative Diseases Drug Value Market Share Forecast by Type (2022-2027)
Table Global Neurodegenerative Diseases Drug Value (Million USD) Forecast by Application (2022-2027)
Table Global Neurodegenerative Diseases Drug Value Market Share Forecast by Application (2022-2027)
Table Global Neurodegenerative Diseases Drug Value (Million USD) Forecast by Region (2022-2027)
Table Global Neurodegenerative Diseases Drug Value Market Share Forecast by Region (2022-2027)
Table UCB S.A Company Information
Table UCB S.A Product Introduction
Table UCB S.A Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Teva Pharmaceuticals Company Information
Table Teva Pharmaceuticals Product Introduction
Table Teva Pharmaceuticals Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Sanofi Company Information
Table Sanofi Product Introduction
Table Sanofi Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Roche Company Information
Table Roche Product Introduction
Table Roche Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Pfizer Company Information
Table Pfizer Product Introduction
Table Pfizer Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Orion Pharma Ltd Company Information
Table Orion Pharma Ltd Product Introduction
Table Orion Pharma Ltd Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Novartis Company Information
Table Novartis Product Introduction
Table Novartis Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Mitsubishi Tanabe Pharma America Company Information
Table Mitsubishi Tanabe Pharma America Product Introduction
Table Mitsubishi Tanabe Pharma America Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Lundbeck Pharmaceuticals Italy S.p.A. Company Information
Table Lundbeck Pharmaceuticals Italy S.p.A. Product Introduction
Table Lundbeck Pharmaceuticals Italy S.p.A. Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)
Table Biogen Company Information
Table Biogen Product Introduction
Table Biogen Neurodegenerative Diseases Drug Sales Value, Gross Margin and Global Share (2019-2021)